Table 2.
Characterization of vaxEffect@UniMiB users for the gender stratification.a
| Gender | Medical history (N=2733), n (%) | Dose 1 | Dose 2 | Dose 3 | |||||
|
|
|
Admin.b (N=2360), n (%) | ADRc (N=2226), n (%) | Admin. (N=1779), n (%) | ADR (N=1610), n (%) | Admin. (N=179), n (%) | ADR (N=169), n (%) | ||
| Male | 1224 (44.8) | 1075 (45.6) | 998 (44.8) | 713 (40.1) | 645 (40.1) | 68 (38.0) | 65 (38.5) | ||
| Female | 1509 (55.2) | 1285 (54.4) | 1228 (55.2) | 1066 (59.9) | 965 (59.9) | 111 (62.0) | 104 (61.5) | ||
aEach cell reports the absolute and the relative frequency computed for the sample size N reported in the column headings.
bAdmin.: individuals who submitted their vaccination data.
cADR: adverse drug reaction (individuals who registered their ADRs 7 days postvaccination).